Abdiel Capital Advisors LP Makes New Investment in HCA Healthcare, Inc. $HCA

Key Points

• Abdiel Capital Advisors LP has acquired 477,021 shares of HCA Healthcare, valued at approximately $164.8 million, making it the second largest position in their portfolio.
• HCA Healthcare reported earnings of $6.84 per share for the last quarter, exceeding analysts' expectations, with revenue of $18.61 billion.
• The company recently declared a quarterly dividend of $0.72 per share, representing an annualized dividend yield of 0.7%, with a payout ratio of 12.11%.

Abdiel Capital Advisors LP bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 477,021 shares of the company's stock, valued at approximately $164,835,000. HCA Healthcare comprises about 17.0% of Abdiel Capital Advisors LP's holdings, making the stock its 2nd largest position. Abdiel Capital Advisors LP owned about 0.20% of HCA Healthcare at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of HCA. Brighton Jones LLC purchased a new position in HCA Healthcare in the fourth quarter worth $1,021,000. Ameriprise Financial Inc. boosted its position in HCA Healthcare by 65.3% in the fourth quarter. Ameriprise Financial Inc. now owns 438,680 shares of the company's stock worth $131,668,000 after purchasing an additional 173,330 shares during the last quarter. Baird Financial Group Inc. lifted its position in shares of HCA Healthcare by 5.3% during the 4th quarter. Baird Financial Group Inc. now owns 29,278 shares of the company's stock valued at $8,788,000 after buying an additional 1,473 shares during the last quarter. Cary Street Partners Financial LLC purchased a new position in shares of HCA Healthcare during the 4th quarter valued at $187,000. Finally, BOKF NA lifted its position in shares of HCA Healthcare by 29.6% during the 4th quarter. BOKF NA now owns 5,401 shares of the company's stock valued at $1,636,000 after buying an additional 1,232 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on HCA. Wolfe Research cut HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research report on Monday, July 28th. Bank of America lowered HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price objective on the stock. in a research note on Wednesday, July 16th. Morgan Stanley decreased their price objective on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a research note on Monday, July 28th. Truist Financial boosted their price objective on HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a research note on Wednesday, July 16th. Finally, JPMorgan Chase & Co. boosted their price objective on HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a research note on Monday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $401.83.

HCA Healthcare Price Performance

Shares of HCA traded up $9.09 during midday trading on Friday, reaching $420.68. The stock had a trading volume of 1,059,770 shares, compared to its average volume of 1,054,336. The company's 50-day moving average is $380.14 and its 200 day moving average is $360.12. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $420.98. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. The company has a market capitalization of $98.43 billion, a price-to-earnings ratio of 17.68, a price-to-earnings-growth ratio of 1.32 and a beta of 1.41.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. During the same period in the prior year, the business earned $5.50 EPS. The company's revenue for the quarter was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be issued a dividend of $0.72 per share. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare's dividend payout ratio is currently 12.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.